Market Cap | 6.82B | P/E | - | EPS this Y | 38.10% | Ern Qtrly Grth | - |
Income | -239.78M | Forward P/E | -66.70 | EPS next Y | 30.40% | 50D Avg Chg | 3.00% |
Sales | 631.73M | PEG | -0.31 | EPS past 5Y | - | 200D Avg Chg | 26.00% |
Dividend | N/A | Price/Book | 8.50 | EPS next 5Y | 51.40% | 52W High Chg | -8.00% |
Recommedations | 2.30 | Quick Ratio | 4.25 | Shares Outstanding | 106.44M | 52W Low Chg | 147.00% |
Insider Own | 2.18% | ROA | -11.95% | Shares Float | 104.40M | Beta | 1.85 |
Inst Own | 96.99% | ROE | -31.61% | Shares Shorted/Prior | 7.81M/10.42M | Price | 58.70 |
Gross Margin | 64.70% | Profit Margin | -37.96% | Avg. Volume | 943,083 | Target Price | 27.43 |
Oper. Margin | -27.26% | Earnings Date | Oct 31 | Volume | 1,672,968 | Change | -5.70% |
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Stephens & Co. | Overweight | Sep 4, 24 |
Leerink Partners | Outperform | Sep 3, 24 |
UBS | Neutral | Aug 13, 24 |
Morgan Stanley | Overweight | Aug 13, 24 |
Canaccord Genuity | Buy | Jul 23, 24 |
Jefferies | Buy | Jul 22, 24 |
B of A Securities | Neutral | Jul 18, 24 |
JP Morgan | Neutral | Jul 18, 24 |
Stifel | Buy | Jul 16, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Dec 14 | Sell | 54.77 | 2,000 | 109,540 | 845,446 | 12/18/23 |
Wilbur James | Chief Commercial Off.. Chief Commercial Officer | Nov 22 | Sell | 43.3367 | 3,464 | 150,118 | 83,342 | 11/27/23 |
Hindson Benjamin J. | See Remarks See Remarks | Nov 22 | Sell | 43.3367 | 3,449 | 149,468 | 277,338 | 11/27/23 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Nov 22 | Sell | 43.3367 | 1,679 | 72,762 | 97,105 | 11/27/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Nov 22 | Sell | 43.53 | 7,480 | 325,604 | 847,446 | 11/27/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Sep 14 | Sell | 49.59 | 2,000 | 99,180 | 862,093 | 09/18/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Aug 22 | Sell | 45.7811 | 3,757 | 172,000 | 864,093 | 08/24/23 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Aug 22 | Sell | 45.7811 | 1,678 | 76,821 | 98,784 | 08/24/23 |
Wilbur James | Chief Commercial Off.. Chief Commercial Officer | Aug 22 | Sell | 45.7811 | 9,699 | 444,031 | 101,253 | 08/24/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Aug 14 | Sell | 50.26 | 2,000 | 100,520 | 867,850 | 08/16/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Jul 19 | Sell | 60.03 | 40,000 | 2,401,200 | 869,850 | 07/21/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Jul 19 | Option | 5.04 | 20,845 | 105,059 | 909,850 | 07/21/23 |
Hindson Benjamin J. | See Remarks See Remarks | Jul 19 | Sell | 60.03 | 13,940 | 836,818 | 284,236 | 07/21/23 |
Hindson Benjamin J. | See Remarks See Remarks | Jul 19 | Option | 8.26 | 13,940 | 115,144 | 298,176 | 07/21/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Jul 14 | Sell | 57.99 | 2,000 | 115,980 | 889,005 | 07/18/23 |
STUELPNAGEL JOHN R | Director Director | Jun 05 | Sell | 54.8894 | 10,000 | 548,894 | 333,736 | 06/07/23 |
Hindson Benjamin J. | See Remarks See Remarks | May 23 | Sell | 55.06 | 2,388 | 131,483 | 284,236 | 05/25/23 |
Wilbur James | Chief Commercial Off.. Chief Commercial Officer | May 23 | Sell | 55.0653 | 316 | 17,401 | 110,952 | 05/25/23 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | May 23 | Sell | 55.06 | 1,665 | 91,675 | 100,462 | 05/25/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | May 19 | Sell | 55.06 | 2,602 | 143,266 | 893,190 | 05/23/23 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Feb 22 | Sell | 47.7533 | 1,245 | 59,453 | 75,519 | 02/24/23 |
Hindson Benjamin J. | See Remarks See Remarks | Feb 22 | Sell | 47.7533 | 1,742 | 83,186 | 250,237 | 02/24/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Feb 22 | Sell | 47.7533 | 1,941 | 92,689 | 909,715 | 02/24/23 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Nov 22 | Sell | 34.07 | 2,676 | 91,171 | 974,926 | 11/23/22 |
Hindson Benjamin J. | See Remarks See Remarks | Nov 22 | Sell | 34.07 | 2,361 | 80,439 | 217,713 | 11/23/22 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Nov 22 | Sell | 34.07 | 1,626 | 55,398 | 76,764 | 11/23/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Sep 12 | Option | 1.2 | 11,500 | 13,800 | 977,602 | 09/14/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Aug 23 | Sell | 35.1913 | 2,715 | 95,544 | 966,102 | 08/25/22 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Aug 23 | Sell | 35.1913 | 987 | 34,734 | 58,092 | 08/25/22 |
Hindson Benjamin J. | See Remarks See Remarks | Aug 23 | Sell | 35.1913 | 1,292 | 45,467 | 186,246 | 08/25/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | May 23 | Sell | 48.7636 | 2,656 | 129,516 | 968,817 | 05/25/22 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | May 23 | Sell | 48.7641 | 967 | 47,155 | 59,079 | 05/25/22 |
Hindson Benjamin J. | See Remarks See Remarks | May 23 | Sell | 48.7636 | 1,264 | 61,637 | 187,538 | 05/25/22 |
CRUTCHFIELD BRADFORD | Chief Commercial Off.. Chief Commercial Officer | May 23 | Sell | 48.7642 | 286 | 13,947 | 97,237 | 05/25/22 |
Kosaraju Sridhar | Director Director | May 16 | Option | 11.48 | 15,000 | 172,200 | 18,458 | 05/17/22 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | May 13 | Buy | 40.4855 | 158 | 6,397 | 60,046 | 05/17/22 |
CRUTCHFIELD BRADFORD | Chief Commercial Off.. Chief Commercial Officer | May 13 | Buy | 40.4855 | 158 | 6,397 | 97,523 | 05/17/22 |
Hindson Benjamin J. | See Remarks See Remarks | Feb 22 | Sell | 78.5944 | 360 | 28,294 | 160,326 | 02/24/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Feb 22 | Sell | 78.6003 | 551 | 43,309 | 912,742 | 02/24/22 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Feb 22 | Sell | 78.5994 | 288 | 22,637 | 38,531 | 02/24/22 |
CRUTCHFIELD BRADFORD | Chief Commercial Off.. Chief Commercial Officer | Feb 22 | Sell | 78.5993 | 288 | 22,637 | 97,365 | 02/24/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Feb 08 | Option | 11.48 | 3,038 | 34,876 | 925,293 | 02/10/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Feb 08 | Sell | 89.67 | 12,000 | 1,076,040 | 913,293 | 02/10/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Jan 04 | Option | 11.48 | 3,037 | 34,865 | 937,255 | 01/06/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Jan 04 | Sell | 142.08 | 15,000 | 2,131,200 | 922,255 | 01/06/22 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Dec 28 | Option | 1.2 | 56,363 | 67,636 | 934,218 | 12/30/21 |
Hindson Benjamin J. | See Remarks See Remarks | Dec 28 | Option | 1.14 | 113,920 | 129,869 | 160,686 | 12/30/21 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Dec 07 | Option | 8.26 | 8,246 | 68,112 | 892,855 | 12/09/21 |
Saxonov Serge | Chief Executive Offi.. Chief Executive Officer | Dec 07 | Sell | 144.79 | 15,000 | 2,171,850 | 877,855 | 12/09/21 |
McAnear Justin J. | Chief Financial Offi.. Chief Financial Officer | Dec 01 | Option | 5.04 | 10,000 | 50,400 | 48,819 | 12/03/21 |